Ravi Misra
Stock Analyst at Truist Securities
(0.70)
# 4,018
Out of 5,182 analysts
10
Total ratings
50%
Success rate
-11.87%
Average return
Main Sectors:
Stocks Rated by Ravi Misra
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TFX Teleflex | Maintains: Hold | $120 → $135 | $123.18 | +9.60% | 2 | Dec 18, 2025 | |
| IART Integra LifeSciences Holdings | Reiterates: Hold | $15 → $13 | $10.24 | +26.95% | 1 | Nov 3, 2025 | |
| TDOC Teladoc Health | Downgrades: Hold | $42 → $35 | $5.22 | +570.50% | 2 | Aug 2, 2022 | |
| ALGN Align Technology | Upgrades: Buy | $683 | $180.67 | +278.04% | 3 | Apr 22, 2021 | |
| NNOX Nano-X Imaging | Initiates: Buy | $65 | $2.38 | +2,631.09% | 1 | Sep 15, 2020 | |
| GKOS Glaukos | Upgrades: Buy | $65 | $119.49 | -45.60% | 1 | Jan 6, 2020 |
Teleflex
Dec 18, 2025
Maintains: Hold
Price Target: $120 → $135
Current: $123.18
Upside: +9.60%
Integra LifeSciences Holdings
Nov 3, 2025
Reiterates: Hold
Price Target: $15 → $13
Current: $10.24
Upside: +26.95%
Teladoc Health
Aug 2, 2022
Downgrades: Hold
Price Target: $42 → $35
Current: $5.22
Upside: +570.50%
Align Technology
Apr 22, 2021
Upgrades: Buy
Price Target: $683
Current: $180.67
Upside: +278.04%
Nano-X Imaging
Sep 15, 2020
Initiates: Buy
Price Target: $65
Current: $2.38
Upside: +2,631.09%
Glaukos
Jan 6, 2020
Upgrades: Buy
Price Target: $65
Current: $119.49
Upside: -45.60%